BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15134624)

  • 1. Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery.
    Vavra M; Ali MJ; Kang EW; Navalitloha Y; Ebert A; Allen CV; Groothuis DR
    Neuro Oncol; 2004 Apr; 6(2):104-12. PubMed ID: 15134624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion.
    Groothuis DR; Ward S; Itskovich AC; Dobrescu C; Allen CV; Dills C; Levy RM
    J Neurosurg; 1999 Feb; 90(2):321-31. PubMed ID: 9950504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters.
    Ali MJ; Navalitloha Y; Vavra MW; Kang EW; Itskovich AC; Molnar P; Levy RM; Groothuis DR
    Neuro Oncol; 2006 Apr; 8(2):109-18. PubMed ID: 16533759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models.
    Spence AM; Graham MM; Muzi M; Freeman SD; Link JM; Grierson JR; O'Sullivan F; Stein D; Abbott GL; Krohn KA
    J Nucl Med; 1997 Apr; 38(4):617-24. PubMed ID: 9098213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
    Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
    Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
    J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors.
    Navalitloha Y; Schwartz ES; Groothuis EN; Allen CV; Levy RM; Groothuis DR
    Neuro Oncol; 2006 Jul; 8(3):227-33. PubMed ID: 16775223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy.
    Noble CO; Krauze MT; Drummond DC; Yamashita Y; Saito R; Berger MS; Kirpotin DB; Bankiewicz KS; Park JW
    Cancer Res; 2006 Mar; 66(5):2801-6. PubMed ID: 16510602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
    Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
    Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
    Shi M; Fortin D; Paquette B; Sanche L
    Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note.
    Tanner PG; Holtmannspötter M; Tonn JC; Goldbrunner R
    Neurosurgery; 2007 Oct; 61(4):E880-2; discussion E882. PubMed ID: 17986926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.
    Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR
    J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
    Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
    Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
    Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T
    Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration.
    Groothuis DR; Benalcazar H; Allen CV; Wise RM; Dills C; Dobrescu C; Rothholtz V; Levy RM
    Brain Res; 2000 Feb; 856(1-2):281-90. PubMed ID: 10677637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.